| 1999 |
HSPB6/Hsp20 is phosphorylated on Ser16 during cyclic nucleotide-dependent relaxation in bovine carotid artery smooth muscle. Phosphorylation state-specific antibodies confirmed Ser16 phosphorylation, and synthetic phosphopeptides containing phospho-Ser16 inhibited contractile responses, indicating Ser16 phosphorylation modulates cAMP-dependent vasorelaxation. |
2D isoelectric focusing immunoblots, phosphorylation state-specific antibodies, synthetic phosphopeptide functional assay in permeabilized smooth muscle |
The Journal of biological chemistry |
High |
10196226
|
| 1999 |
Phosphorylation of Hsp20 in vascular smooth muscle is associated with dissociation of macromolecular aggregates of Hsp20, and this dissociation correlates with changes in macromolecular associations of myosin light chains (MLC20). PKA-mediated phosphorylation in vitro also caused aggregate dissociation, suggesting Hsp20 may regulate vasorelaxation through direct interaction with contractile regulatory proteins. |
Molecular sieve chromatography, subcellular fractionation, in vitro PKA phosphorylation, isoelectric focusing immunoblots |
The Journal of biological chemistry |
High |
10037721
|
| 1998 |
Recombinant rat Hsp20 forms predominantly 43-kDa dimers and 470-kDa multimers in solution, with the ratio depending on protein concentration. Hsp20 has markedly lower chaperone-like activity than alphaB-crystallin in insulin B-chain aggregation assays. |
Recombinant protein expression in E. coli, size-exclusion chromatography, circular dichroism, 1H-NMR, in vitro chaperone assay |
European journal of biochemistry |
High |
9990320
|
| 2003 |
In rat heart, Hsp20 localizes predominantly to the cytosol and co-fractionates with alphaB-crystallin in ~200 kDa complexes. AlphaB-crystallin co-immunoprecipitates with Hsp20. Phosphopeptide analogues of Hsp20 introduced into permeabilized cardiomyocytes increased myocyte shortening rate and were associated with accelerated calcium transient decay. |
Subcellular fractionation, size-exclusion chromatography, co-immunoprecipitation, immunofluorescence microscopy, functional phosphopeptide transduction assay |
Circulation |
High |
12551873
|
| 2004 |
Hsp20 protects cardiomyocytes from beta-agonist-induced apoptosis in a phosphorylation-dependent manner: constitutively phosphorylated S16D mutant conferred full protection, whereas the non-phosphorylatable S16A mutant showed no antiapoptotic effect. Hsp20 translocates to the cytoskeleton and associates with actin upon isoproterenol stimulation. |
Adenoviral overexpression in adult rat cardiomyocytes, TUNEL assay, DNA laddering, caspase-3 activity assay, immunostaining, co-immunoprecipitation with actin antibodies |
Circulation research |
High |
15105294
|
| 2004 |
Human Hsp20 and its phosphomimetic S16D mutant form small oligomers (~55–60 kDa by SEC, dimers by crosslinking) rather than large multimers. At neutral pH, Hsp20 exhibits chaperone activity (preventing insulin and ADH aggregation) comparable to or higher than commercial alpha-crystallin, whereas the S16D mutant shows reduced chaperone activity. Hsp20 forms hetero-oligomeric complexes with Hsp27. |
Recombinant expression in E. coli, size-exclusion chromatography, chemical crosslinking, in vitro chaperone aggregation assays |
European journal of biochemistry |
High |
14717697
|
| 2004 |
Phosphopeptide analogues of Hsp20 (containing phospho-Ser16 and a protein transduction domain) introduced into Swiss 3T3 cells caused loss of actin stress fibers and focal adhesion complexes, and dephosphorylation of cofilin. Pull-down assays showed that 14-3-3 proteins bound phospho-Hsp20 peptides but not non-phosphorylated analogues, and this binding prevented cofilin from associating with 14-3-3. |
Protein transduction of synthetic phosphopeptides, immunocytochemistry, interference reflection microscopy, biochemical actin quantitation, pull-down assay |
FASEB journal |
High |
15598710
|
| 2003 |
Transduction of phospho-Hsp20 peptide analogues (PTD-pHSP20) into porcine coronary artery smooth muscle induced dose-dependent relaxation without changing endogenous Hsp20 phosphorylation status (mass spectrometric immunoassay showed no mass shift of endogenous Hsp20), suggesting that phospho-Hsp20 peptides act directly on downstream targets rather than via kinase activation. |
Protein transduction, muscle bath functional assay, mass spectrometric immunoassay (MSIA), fluorescence microscopy |
FASEB journal |
Medium |
12738803
|
| 2006 |
Hsp20 colocalized with ASK1 in cardiomyocytes and attenuated the ASK1-JNK/p38 signaling cascade triggered by isoproterenol, protecting against beta-agonist-induced cardiac remodeling. Parallel in vitro experiments showed inhibitory role of Hsp20 on enforced ASK1-JNK/p38 activation. |
Transgenic mouse model (cardiac-specific 10-fold overexpression), immunostaining co-localization, Western blot of ASK1/JNK/p38 pathway, in vitro H9c2 and adult rat cardiomyocyte experiments |
Circulation research |
Medium |
17068291
|
| 2009 |
Blockade of Hsp20 phosphorylation at Ser16 (S16A transgenic model) attenuates cardioprotection against ischemia/reperfusion injury, suppresses autophagy, and shifts Hsp20 oligomerization toward higher aggregates. Rapamycin pretreatment (autophagy activator) rescued functional recovery in S16A hearts, establishing that Ser16 phosphorylation of Hsp20 promotes cardioprotection at least partly through enabling autophagy. |
Cardiac-specific transgenic mouse with S16A-Hsp20, ex vivo I/R, autophagy markers, rapamycin rescue experiment, gel filtration for oligomerization |
Circulation research |
High |
19850943
|
| 2006 |
Phosphorylated Hsp20 (pSer16) forms a tight complex with 14-3-3gamma as a dimer:dimer complex. Unphosphorylated Hsp20 and the S16D phosphomimetic mutant did not interact with 14-3-3. 14-3-3 increased the chaperone activity of phosphorylated Hsp20 toward insulin substrates. |
Size-exclusion chromatography, chemical crosslinking, in vitro chaperone assays with phosphorylated and unphosphorylated Hsp20 |
Molecular and cellular biochemistry |
High |
17109079
|
| 2008 |
HspB6/Hsp20 forms heterooligomeric complexes with HspB1/Hsp27 of at least two sizes (100–150 kDa and 250–300 kDa) in a temperature-dependent manner. Within these complexes, wild-type HspB1 inhibits PKA-mediated phosphorylation of HspB6, while the phosphomimetic 3D-HspB1 mutant does not. Conversely, HspB6 inhibits MAPKAP2-mediated phosphorylation of HspB1 within the complexes. |
Native gel electrophoresis, analytical ultracentrifugation, chemical cross-linking, size-exclusion chromatography, in vitro kinase assays |
Biochimica et biophysica acta |
High |
19100870
|
| 2009 |
HspB8 and HspB6 bind to Bag3 through the hydrophobic groove formed by beta4/beta8 strands of the alpha-crystallin domain. Two IPV (Ile-Pro-Val) motifs in Bag3 mediate binding to both HspB8 and HspB6. HspB6–Bag3 complex promotes clearance of aggregated mutant huntingtin (Htt43Q). |
Co-immunoprecipitation, deletion mutagenesis mapping, cell-based aggregation clearance assay (Htt43Q) |
The Biochemical journal |
High |
19845507
|
| 2009 |
Crystal structures of the alpha-crystallin domain of rat Hsp20 show that it forms homodimers with a shared groove at the interface by beta-sheet extension. The groove in Hsp20 is partially filled by a peptide in polyproline II conformation in the crystal. The dimer structure has empty pockets likely filled by N-terminal extension motifs in full-length chains, and contains a conserved arginine at the symmetry-related functional site. |
X-ray crystallography |
Journal of molecular biology |
High |
19646995
|
| 2011 |
Disruption of the HSP20–PDE4 interaction (using a cell-permeable inhibitory peptide derived from peptide array analysis) is sufficient to induce PKA-mediated phosphorylation of HSP20 and protect against hypertrophic response in neonatal cardiac myocytes following chronic beta-adrenergic stimulation. FRET-based cAMP reporters anchored to HSP20 showed larger response to PDE4 inhibition than free cytosolic reporters, indicating PDE4 creates a local cAMP microdomain that regulates HSP20 phosphorylation. |
Peptide array, in vitro binding, co-immunoprecipitation, immunocytochemistry, FRET-based cAMP reporters, cell-permeable peptide disruption, hypertrophy assay |
Journal of molecular and cellular cardiology |
High |
21334344
|
| 2011 |
AKAP-Lbc (AKAP13) is the A-kinase-anchoring protein responsible for directing PKA phosphorylation of Hsp20 on Ser16. Gene silencing of AKAP-Lbc reduces Hsp20 Ser16 phosphorylation and abrogates the anti-apoptotic effects of Hsp20 in cardiomyocytes. PKA anchoring disruptor peptides confirmed an AKAP requirement for this modification. |
PKA anchoring disruptor peptides, co-immunoprecipitation, immunofluorescence, siRNA gene silencing, rescue experiments, apoptosis assays |
The Biochemical journal |
High |
22731613
|
| 2012 |
Loss of AC9 (adenylyl cyclase type 9) in mice significantly decreases basal phosphorylation of Hsp20 in heart and reduces Hsp20-associated AC activity. Hsp20 binds AC9 in a Yotiao-independent manner. Expression of catalytically inactive AC9 in neonatal cardiomyocytes decreases isoproterenol-stimulated Hsp20 phosphorylation. AC9 knockout mice show grade 1 diastolic dysfunction. |
AC9 knockout mouse, co-immunoprecipitation, catalytically inactive AC9 expression in neonatal cardiomyocytes, PKA phosphorylation assay, Doppler echocardiography |
Scientific reports |
High |
28717248
|
| 2012 |
Hsp20 is secreted from cardiomyocytes via exosomes through an ER-Golgi-independent pathway. Extracellular Hsp20 binds VEGFR2 (confirmed by protein binding assay and immunostaining) and dose-dependently promotes HUVEC proliferation, migration, and tube formation. A VEGFR2 neutralizing antibody and VEGFR inhibitor blocked these effects. |
Exosome isolation, ER-Golgi inhibitor treatment, protein binding assay, immunostaining co-localization with VEGFR2, HUVEC proliferation/migration/tube formation assays, VEGFR2 blocking antibody |
PloS one |
High |
22427880
|
| 2013 |
Human HSPB6 exists as a stable dimer in solution. The crystal structure reveals typical ACD dimers that further form tetrameric assemblies through extensive inter-dimer patching of beta4/beta8 grooves by tripeptide motifs from the N-terminal domain adjacent to the ACD. Solution SAXS combined with crystallography provides a molecular model of full-length HSPB6. The N-terminal domain dictates chaperone activity and self-interaction. |
X-ray crystallography, SAXS, mutagenesis, size-exclusion chromatography, chaperone activity assays |
Journal of structural biology |
High |
24382496
|
| 2011 |
Acetylation of Hsp20 is a post-translational modification regulated by HDAC8, a non-nuclear lysine deacetylase that interacts with Hsp20. A selective HDAC8 inhibitor increases Hsp20 acetylation and inhibits spontaneous and oxytocin-augmented contractions of human myometrial tissue strips, without elevating histone acetylation. The mechanism involves liberation of cofilin. |
HDAC8 interaction with Hsp20 (co-IP), HDAC8 inhibitor treatment, ex vivo myometrial contractility assay, acetylation biochemistry |
The Journal of biological chemistry |
High |
21803775
|
| 2016 |
Hsp20 directly interacts with Tsg101 in cardiomyocytes, promoting increased generation and secretion of exosomes. Hsp20-TG cardiomyocyte-derived exosomes contain higher levels of Hsp20, p-Akt, survivin, and SOD1 and protect against hyperglycemia-triggered cell death. Blockade of exosome generation by GW4869 abrogated Hsp20-mediated cardioprotection in diabetic mice. |
Transgenic mouse model, co-immunoprecipitation (Hsp20-Tsg101), exosome isolation, GW4869 exosome inhibitor, in vitro hyperglycemia assay, STZ diabetes model |
Diabetes |
High |
27284111
|
| 2018 |
Wild-type HSPB6 interacts with BECN1/Beclin 1, prevents its ubiquitination and proteasomal degradation, competitively suppresses BCL2 binding to BECN1, and thereby stimulates autophagy. A disease-associated human mutant HSPB6S10F has reduced interaction with BECN1, leading to BECN1 ubiquitination, suppressed autophagy flux, increased apoptosis, and cardiac remodeling. Preinhibition of autophagy attenuated wild-type HSPB6 cardioprotection. |
Transgenic mouse cardiac expression of WT and S10F mutant, co-immunoprecipitation (HSPB6-BECN1), ubiquitination assays, autophagy flux measurement, apoptosis assays, autophagy inhibition rescue experiment |
Autophagy |
High |
29157081
|
| 2015 |
Hsp20 forms a complex with PKD1 (protein kinase D1) that is essential for PKD1 nuclear translocation during cardiac hypertrophy. A cell-permeable peptide disrupting the Hsp20-PKD1 complex inhibits PKD1 nuclear translocation, activation of the fetal gene programme, and pathological cardiac fibrosis. |
Peptide array mapping of Hsp20 binding site on PKD1, cell-permeable disruptor peptide, immunofluorescence tracking of PKD1 nuclear translocation, gene expression (fetal programme), fibrosis assays |
Cell communication and signaling |
Medium |
25889640
|
| 2018 |
Hsp20 controls adipocyte function by interacting with the ubiquitin ligase subunit FBXO4 and regulating ubiquitin-dependent degradation of PPARγ. Hsp20 deletion enhances non-shivering thermogenesis, improves glucose and lipid metabolism, and mimics pharmacological PPARγ agonist effects. The interaction links beta-adrenergic signaling to PPARγ activity. |
Hsp20 knockout mouse, co-immunoprecipitation (Hsp20-FBXO4), ubiquitination assays of PPARγ, metabolic phenotyping, brown/beige adipocyte functional assays |
Cell reports |
High |
29925002
|
| 2014 |
HSPB6/Hsp20 directly associates with Bax (co-immunoprecipitation), enhances caspase-3 and caspase-7 cleavage, and increases PARP cleavage in human HCC cells. Bad, Bcl-2, and Bcl-xL were not co-immunoprecipitated with HSP20, indicating a selective interaction with Bax that stimulates the caspase cascade. |
Co-immunoprecipitation, caspase activity/cleavage assays, PARP cleavage, overexpression in HuH7 cells |
Oncology reports |
Medium |
24969689
|
| 2013 |
HSP20/HSPB6 directly associates with both the p85 regulatory subunit and p110 catalytic subunit of PI3K in human HCC cells (co-immunoprecipitation). HSP20 overexpression downregulates PI3K activity in unstimulated and TGF-α-stimulated cells without affecting PI3K expression levels, reducing downstream AKT signaling. |
Co-immunoprecipitation (p85 and p110), PI3K activity assay, Western blot for pathway readouts, in vivo human HCC tissue validation |
PloS one |
Medium |
24223153
|
| 2002 |
Hsp20 acts extracellularly as a regulator of platelet function: dissociated (non-aggregated) form of HSP20 is present in plasma, human platelets have specific binding sites for HSP20, and extracellular HSP20 markedly reduces thrombin-induced phosphoinositide hydrolysis by phospholipase C. Vessel wall HSP20 levels were reduced after endothelial injury. |
Sucrose density gradient centrifugation, Western blotting, immunohistochemistry, specific binding site assay on platelets, phospholipase C activity assay |
Life sciences |
Medium |
12417245
|
| 2000 |
Hsp20 inhibits receptor-mediated calcium influx in human platelets without affecting intracellular calcium release (tested using fura-2 imaging). Hsp20 inhibited thrombin- and collagen-induced calcium influx but not A-23187-induced calcium entry. Hsp28 failed to affect platelet cytoplasmic calcium, indicating specificity. |
Fura-2 fluorescent calcium imaging in human platelets, pharmacological dissection of calcium sources |
Life sciences |
Medium |
10658928
|
| 2011 |
HSPB6 overexpression protects tachypaced atrial myocytes against RhoA GTPase-induced remodeling by direct prevention of F-actin stress fiber formation (independently of inhibiting RhoA GTPase activity itself, which is the HSPB8 mechanism). HSPB6 protection was independent of HSPB1. |
HL-1 atrial myocyte tachypacing model, overexpression, calcium transient measurement, RhoA GTPase activity assay, F-actin stress fiber imaging, ROCK inhibitor control |
PloS one |
Medium |
21731611
|
| 2014 |
The N-terminal domain of HSPB6 is essential for chaperone activity; systematic deletion mapping showed no single truncation except complete removal of the N-terminal domain abolished activity. Residues 31–35 act as a negative regulator of chaperone activity (deletion enhances activity), with Q31 and F33 specifically fine-tuning function through mutagenesis. Structural analysis by SEC/SAXS confirmed dimeric structure of most mutants. |
Iterative deletion mutagenesis, size-exclusion chromatography, SAXS, chaperone activity assays with three different substrates, single-point mutagenesis |
PloS one |
High |
25157403
|
| 2017 |
The N-terminal domain of HSPB6 governs preferential hetero-oligomerization with HSPB1. Three functional elements were identified: (1) the conserved RLFDQXFG motif is necessary for subunit exchange among oligomers; (2) a site ~20 residues downstream determines hetero-oligomer size; (3) a region unique to HSPB6 dictates preferential heterodimer formation. When mixed in vitro, HSPB6 and HSPB1 form exclusively heterodimers. |
Iterative deletion mapping of HSPB6 N-terminal domain, in vitro mixing, native MS (mass spectrometry), SEC |
The Journal of biological chemistry |
High |
28487364
|
| 2006 |
Tissue transglutaminase (tTG) crosslinks Hsp20 via transamidation at Q31 and C-terminal K162, identified by mass spectrometric peptide fingerprinting and fragmentation. Q31 is a conserved glutamine in sHSPs, and its reactivity is determined by the neighboring residue. Simultaneous highly efficient deamidation of Q66 also occurs. |
Hexapeptide probes for tTG activity, mass spectrometric peptide mass fingerprinting, peptide fragmentation |
Proteins |
Medium |
16385579
|
| 2014 |
Hsp20 phosphorylation enhances its association with amyloid-beta (Aβ). NMR, peptide array, and co-immunoprecipitation mapping showed Hsp20 binds adjacent to the oligomerization domain of Aβ, preventing aggregation. Phospho-Hsp20 shows increased association with low molecular weight Aβ species and requires lower concentrations to disrupt amyloid oligomers. Hsp20 N-terminal 25-mers inhibit Aβ fibril formation. |
Peptide array, co-immunoprecipitation, NMR, real-time fluorescent Aβ aggregation assay, MTT assay, cell impedance measurement |
Molecular and cellular neurosciences |
High |
24859569
|
| 2007 |
cAMP/PKA-dependent phosphorylation of Hsp20 in airway smooth muscle (ASM) is required for relaxation: PKI (PKA inhibitory fusion protein) expressing cells failed to phosphorylate Hsp20 or lose actin stress fibers upon isoproterenol/forskolin treatment. Phospho-Hsp20 dephosphorylates cofilin in ASM, and phosphopeptide mimetics of Hsp20 partially relax precontracted bovine ASM strips. |
PKI-GFP stable expression, isoproterenol/forskolin treatment, 2D immunoblots, cofilin phosphorylation assay, actin stress fiber immunocytochemistry, muscle bath assay |
American journal of physiology. Lung cellular and molecular physiology |
High |
17993590
|
| 2007 |
The C-terminal extension of Hsp20 is essential for cardioprotection against simulated ischemia/reperfusion, as a C-terminal extension substitution mutant failed to protect cardiomyocytes (measured by LDH/CK release), while the same mutant still enhanced calcium transients and cell contraction amplitude comparably to full-length Hsp20, dissociating the chaperone/protective function from the contractile-enhancement function. |
Adenoviral overexpression in neonatal and adult rat cardiomyocytes, simulated I/R, LDH/CK cell viability assays, epifluorescence calcium imaging, cell contraction measurement |
Journal of molecular and cellular cardiology |
Medium |
17292395
|
| 2019 |
Elevated phosphorylated Hsp20 (S16D transgenic) at levels similar to failing human hearts causes fibrotic remodeling, depressed LV function, and heart failure. Mechanistically, phosphorylated Hsp20 translocates to the nucleus and upregulates IL-6, which activates cardiac fibroblasts via STAT3 signaling in a paracrine fashion. Anti-IL-6 receptor antibody treatment attenuated fibrosis. |
S16D-Hsp20 cardiac-specific transgenic mice, nuclear fractionation, IL-6 quantification, STAT3 signaling analysis, anti-IL-6 receptor monoclonal antibody treatment, echocardiography |
JACC. Basic to translational science |
Medium |
31061921
|
| 1999 |
After heat stress in cultured rat neonatal cardiac myocytes, a subpopulation of Hsp20 migrates into the nucleus while another part remains cytoplasmic. In contrast to alphaB-crystallin, Hsp20 remains largely Triton-soluble after heat stress and does not display sarcomeric association, indicating distinct functional behavior despite structural similarity. |
Immunofluorescence microscopy, Triton X-100 solubility fractionation, heat stress experiments in cultured cardiomyocytes |
European journal of cell biology |
Medium |
10494863
|
| 2012 |
Monomeric 14-3-3ζ interacts with phosphorylated HspB6 in a 1:1 complex (vs the 2:1 or 2:2 complex formed by dimeric 14-3-3). Interaction with phosphorylated HspB6 retards proteolytic degradation and increases thermal stability of monomeric 14-3-3. The monomeric 14-3-3 has significantly higher chaperone-like activity than either dimeric 14-3-3 or HspB6 alone. |
Size-exclusion chromatography, chemical crosslinking, proteolysis protection assay, thermal stability measurement, in vitro chaperone assay with myosin S1 |
Biochemistry |
Medium |
22794279
|